HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of endokinin A/B and endokinin C/D on the antinociception properties of hemopressin in mice.

Abstract
The current study evaluated the effects of hemopressin (HP) on pain modulation by endokinin A/B (EKA/B) and endokinin C/D (EKC/D) at the supraspinal level in mice. Intracerebroventricular administration of HP (10 nmol) fully antagonized the hyperalgesia induced by EKA/B (10, 30, and 100 pmol), and induced a dose-dependent potent analgesic effect. HP at different concentrations (10 pmol, 100 pmol, and 1 nmol) showed varying effects on the analgesic effect of EKA/B (3 nmol). HP extended the duration of the analgesic effect of EKC/D (3 nmol). Moreover, HP at different concentrations (10 pmol, 5 pmol, 1 pmol, and 100 fmol) co-administered with EKC/D (30 pmol) induced significant analgesia at two different time points: 5 min and 50 min. To investigate the antinociceptive mechanism, we used SR140333B and SR142801. HP (1 pmol) potentiated the analgesic effect of SR140333B (100 pmol)+EKA/B (30 pmol) in 5-10 min, while HP (100 pmol) had no effect in the analgesia induced by SR140333B (3 nmol)+EKA/B (3 nmol). HP (1 nmol) fully inhibited the analgesic effect of SR140333B (3 nmol)+EKC/D (3 nmol) or SR142801 (3 nmol)+EKC/D (3 nmol). HP (1 pmol) weakened the analgesic effect of SR142801 (100 pmol)+EKA/B (30 pmol), but HP (100pmol) strengthened the analgesic effect of SR142801 (3 nmol)+EKA/B (3 nmol). These findings may pave the way for a new strategy on investigating the interaction between tachykinins and opioids on pain modulation.
AuthorsLanxia Zhou, Qiaoying Jin, Yinliang Yang, Zhengkun Liu, Xiaoli Li, Shouliang Dong, Li Zhao
JournalPeptides (Peptides) Vol. 38 Issue 1 Pg. 70-80 (Nov 2012) ISSN: 1873-5169 [Electronic] United States
PMID22951322 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Analgesics
  • Hemoglobins
  • Neurokinin-1 Receptor Antagonists
  • Peptide Fragments
  • Piperidines
  • Receptors, Neurokinin-3
  • SR140333B
  • Tachykinins
  • Tropanes
  • endokinin A-B, human
  • endokinin C-D, human
  • hemopressin
  • SR 142801
Topics
  • Analgesics (pharmacology)
  • Animals
  • Dose-Response Relationship, Drug
  • Hemoglobins (administration & dosage, pharmacology)
  • Hyperalgesia (chemically induced, drug therapy)
  • Injections, Intraventricular
  • Male
  • Mice
  • Neurokinin-1 Receptor Antagonists
  • Peptide Fragments (administration & dosage, pharmacology)
  • Piperidines (pharmacology)
  • Receptors, Neurokinin-3 (antagonists & inhibitors)
  • Tachykinins (pharmacology)
  • Tropanes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: